These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19238925)

  • 1. [Cardiology].
    Roguelov C; Vogt P; Yerly P; Pascale P; Katz E; Aebischer N
    Rev Med Suisse; 2009 Jan; 5(186):94-100. PubMed ID: 19238925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of new therapies in cardiovascular care. Time for hope or despair for developing countries.
    Omeish AF
    Saudi Med J; 2007 May; 28(5):675-82. PubMed ID: 17457431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update cardiology 2006/2007].
    Fries R; Kilter H; Laufs U; Mewis C; Scheller B; Böhm M
    Med Klin (Munich); 2007 Aug; 102(8):647-58. PubMed ID: 17694284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial note.
    Waksman R
    Cardiovasc Revasc Med; 2009; 10(3):143. PubMed ID: 19595393
    [No Abstract]   [Full Text] [Related]  

  • 6. The year in clinical cardiac electrophysiology.
    Scheinman MM; Keung E
    J Am Coll Cardiol; 2007 May; 49(20):2061-9. PubMed ID: 17512364
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for high risk cardiac diseases in athletes].
    Aupetit JF; Brion R; Carre F
    Arch Mal Coeur Vaiss; 2006 Nov; 99(11):1111-4. PubMed ID: 17181042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
    Ruiz-Nodar JM; Marín F; Sánchez-Payá J; Hurtado JA; Valencia-Martín J; Manzano-Fernández S; Roldán V; Pérez-Andreu V; Sogorb F; Valdés M; Lip GY
    Eur Heart J; 2009 Apr; 30(8):932-9. PubMed ID: 19246502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
    Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
    EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiology -- what is new?].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1540-2. PubMed ID: 15965857
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
    Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
    Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [American Heart Association conference 2008. The JUPITER trial, the approval of prasugrel, the (aging) heart of obese adolescents].
    Schaerlig E
    Rev Med Suisse; 2009 Feb; 5(192):482-5. PubMed ID: 19317316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.